China’s biotech is redrawing the global pharma map; what India can learn
American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma treatment. AstraZeneca signed a deal with CSPC Pharma for a cardiac treatment, while Merck signed a $2 billion deal with Hansoh Pharma.…
{"error": "429 Resource has been exhausted (e.g. check quota)."}